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ABSTRACT 
Objective: The objective of the present study was to formulate site-specific drug delivery of mesalamine using Locust bean gum. 
Methods: The core microspheres were prepared by ionic gelation method using CaCl2
Results: The SEM images revealed the surface morphology was rough and smooth for core and coated microspheres, respectively. The optimized 
batch (ILBG6) of core microspheres(for 7hr), coated microspheres and coated microspheres in presence of rat caecal contents (8%w/v) for 24hr 
exhibited 98.44±2.48, 73.58±3.49 % and 98.28±4.42 drug release, respectively. The drug release from all locust bean gum microsphere formulations 
followed higuchi kinetics. Moreover, drug release from Eudragit S-100 coated microspheres followed the korsmeyer-peppas equation with an 
fickian kinetics mechanism. Finally, stability studies suggested the change in entrapment efficiency and in vitro drug release of microspheres was 
minimal, indicating good stability of the formulation.  
 solution and cross-linked with glutaraldehyde and were 
further coated with pH-sensitive polymer eudragit S-100(1.5-4.5 ml) to retard the drug release in the upper gastrointestinal environment (Stomach 
and small intestine). Microspheres were characterized by ftir spectroscopy, differential scanning calorimetry and evaluated by scanning electron 
microscopy (SEM), particle size analysis, entrapment efficiency and in vitro drug release studies in different simulated gastric fluids. Stability studies 
were carried out for one month at 40±2 °C/75±5% RH.  
Conclusion: The microspheres formed using natural polysaccharide locust beangum by ionic gelation method are capable of colon targeting the 
anti-inflammatory drug, mesalamine for the treatment of ulcerative colitis.  
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Various drug delivery approaches have been explored for successful 
delivery of drugs to the target site. However, the oral route of 
administration is considered to be the most convenient and 
preferred route for a sustained as well as controlled drug delivery 
system [1]. Controlled drug delivery systems offer numerous 
advantages compared to conventional dosage forms such as 
improved efficiency, reduced toxicity and improved patient 
compliance and convenience [2]. Colonic drug delivery has gained 
increased attention not just for the delivery of the drugs for the 
treatment of local diseases associated with the colon but also for its 
potential for the delivery of proteins and therapeutic peptides. Colon 
targeting is naturally of value for the topical treatment of diseases of 
the colon such as Chron’s diseases, ulcerative colitis, colorectal 
cancer, and amoebiasis [3].
However, 5-ASA rapidly absorbs from the small intestine and there 
is little localization of 5-ASA in the colon relative to the small 
intestine. Thus, it is necessary to develop a colon-specific delivery 
system for 5-ASA in the treatment of ulcerative colitis [4]. 
Microspheres form an important part of such novel drug delivery 
systems [5, 6]. In recent years, considerable attention has been 
focused on hydrophilic polymers in the design of oral controlled 
drug delivery systems because of their flexibility to obtain a 
desirable drug release profile, cost-effectiveness, and broad 
regulatory acceptance [7]. These polymeric systems have been the 
potential candidates to deliver bioactive molecules, particularly in 
controlled release applications [8, 9]. Locust bean gum is a high 
molecular weight branch polysaccharide and is extracted from the 
seeds of carob tree Ceratonia siliqua. Being non-ionic, it is not 
affected by pH or ionic strength. It is dispersible in either hot or cold 
water, forming a sol having a pH range 5.4–7.0 [10].  
 5-Aminosalicylic acid (5-ASA), a typical 
anti-inflammatory agent is the drug of choice for the treatment of 
ulcerative colitis.  
The aim of the present research was to formulate a novel colon 
targeted drug delivery of mesalamine by using a natural 
polysaccharide in treating ulcerative colitis because the natural 
polymer can be degraded only in the colon by the bacterial enzymes 
produced by the micro flora of colon.  
MATERIALS AND METHODS 
Mesalamine was obtained as a gift sample from TherDose Pharma 
Pvt Ltd, Hyderabad. Locust bean gum was obtained from Nutriroma 
Pvt. Ltd, Hyderabad. Eudragit S 100 was gifted by Evonik, Germany. 
sodium alginate, calcium chloride, and glutaraldehyde were 
purchased from Sigma-aldrich. All reagents used were analytical 
grade. 
Preparation of microspheres by ionic gelation method  
Locust bean gum microspheres containing mesalamine were 
prepared by ionic gelation method. The drug was dispersed in a 
solution of locust bean gum in WFI (water for injection) until a 
uniform dispersion is formed. The microspheres were formed by 
dropping the bubble free dispersion through a disposable syringe 
(with a nozzle of 24 gauge) into 4% calcium chloride solution and 
allowed curing for 1h. Later separated, washed and dried in an oven 
at 50 °C for 24 h and stored plastic bags for further use(table 1) [11]. 
Preparation of eudragit-coated cross-linked locust bean 
microspheres 
Eudragit coating of GA cross-linked locust bean gum microspheres 
containing MSL were prepared by an oil-in-oil solvent evaporation 
method. Eudragit-S-100 was dissolved in a 10 ml organic solvent 
(2:1, ethanol: acetone) to give either 4:1 or 8:1 ratio. To the above 
coating solution, 100 mg of drug-loaded microspheres were added. 
The above dispersion was then poured into 100 ml of liquid paraffin 
containing 3% of w/v span-80. The above system was agitated at 
1000rpm at 40 °C for 3 h using a mechanical stirrer (Remi, Mumbai, 
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India). The coated microspheres were filtered and washed with n-
hexane to remove the traces of oily phase on the microspheres and 
dried overnight in desiccators and packed in plastic bags until 
further [12]. 
 
Table 1: Formulation for mesalamine microspheres 
Formulation Drug (mg) Polymer (%) GA (ml) SA (%) CC (%) SS (rpm) ST (hr) 
LBG1 100 0.25 1.5 1 4 100 1 
LBG2 100 0.5 1.5 1 4 100 1 
LBG3 100 1 1.5 1 4 100 1 
*LBG-Locust bean gum, GA-Glutaraldehyde, SA-Sodium alginate, CC-Calcium Chloride, SS-Stirring speed, ST-Stirring time 
 
Optimization of formulation variables 
A three-factor two-level full factorial design was used for the 
systemic study of the combination of drug and polymers. 
The main effects (X1and X2) represent the average result of 
changing one factor from its low to high values.  
The interaction term (X1, X2
A 3
) shows how the response values change 
when two factors are simultaneously changed. 
2—factorial design was applied for the experiment where two 
variables (X1
 
, X2) were the amount of matrix forming a polymer and a 
cross-linking agent. The concentration of drug was maintained constant. 
Further, the quantity of drug and a cross-linking agent and controlled 
release matrix forming polymer adjusted in combination as like 1:(1.5-
4.5)i.e.,(-1,+1) and 1:(0.25-1) respectively. By this way totally 12 
formulations were prepared, using Locust bean gum in different 
concentrations by Ionic gelation method. The levels of polymer and 
cross-linking agent are set to low and high values are shown in table 2. 
Table 2: 32
Factors–in-dependant variables 
—full factorial design: factors, factor levels, and responses 
Level LBG in %(X1 CA in ml(X) 2) 
Low level-1 0.25 1.5 
Medium level(0) 0.5 3 
High level+1 1.0 4.5 
Responses-dependant variables 
Y Particle size in mm 1 
Y Entrapment Efficiency in % 2 
Y In vitro drug release 3 
*LBG-Locust bean gum, CA-Cross-linking agent 
 
Characterization of microspheres 
Determination of particle size  
Particle size was measured by optical microscopy (INKO, Ambala, 
India) using a compound microscope. A suspension of MSL 
(mesalamine) microspheres was allowed to dry on a glass slide to 
form a thin film and was mounted onto the stage of the microscope 
and min of 500 particles were measured using an ocular 
micrometer. Each measurement was made in triplicate.  
The mean particle size was calculated using the formula [13]. 
ADM =
n1d1 + n2d2 + ⋯… … … … . +nmdm
n1 + n2 + ⋯… … … … + nm
 
Shape and surface morphology  
The shape and surface morphology of microspheres were 
investigated using Scanning electron microscopy (SEM) (LEO-430, 
Cambridge, U. K). The microspheres were fixed with carbon-glue on 
the supports and gold coated in a high vacuum evaporator using a 
gold sputter module (15Kv) [13]. 
Determination of encapsulation efficiency 
About 50 mg of microspheres were digested in 10 ml Phosphate 
buffer saline (PBS, pH-7.4) and extracted completely during 24 h. 
The solution was centrifuged at 6000rpm. The supernatant filtered 
through a 0.22 µm membrane filter (Millipore) and the amount of 
mesalamine was measured spectrometrically (Shimadzu, Double-
Beam Spectrophotometer, 150-03, Japan) at 212 nm.  
Each determination was made in triplicate [14, 15]. 
Entrapment efficiency (%)  =  
Amount of drug content in microspheres
Amount of drug added × 100 
Fourier-transform infrared (FT-IR) spectroscopy 
Fourier-transform infrared spectrum (FTIR) were recorded for 5-
ASA, locust bean gum, 5-ASA loaded Locust bean gum microspheres 
using spectrum BX (Perkin Elmer) infrared spectrophotometer. KBr 
disks were prepared with samples in them (2 mg sample/200 mg 
KBr) with a hydrostatic press at a force of 40 psi for 4 min. The 
scanning range employed was 450-4000 cm-1
Differential scanning calorimerty (DSC) 
. 
The thermal behavior of for 5-ASA, locust bean gum, 5-ASA loaded 
locust bean gum microspheres observed using a differential 
scanning calorimetry (DSC) Q 10V 8.1 Build 261(Universal V3.9 A 
TA Instruments) thermal analyzer. The carrier gas used for 
analysis was argon with a heating rate of 10 °C/min with a flow 
rate of 35cc/min. The sample size was 5 mg and the temperature 
range was 0 to 300 °C. 
In vitro drug release studies  
The in–vitro drug release studies were performed using USP 
dissolution rate test (paddle apparatus, 100 rpm, 37±0.1 °C). 500 mg 
of microspheres were suspended in 900 ml of dissolution media. For 
the first two hours in simulated gastric fluid (SGF, pH 1.2; without 
pepsin), simulated intestinal fluid(SIF, pH 7.4) mimicking small 
intestine for 3hr and replaced with simulated intestinal 
fluid(SIF,pH6.8) mimicking large intestine environment. Samples 
withdrawn at different time intervals were quantified using UV-
Visible Spectrophotometer (Shimadzu, Kyoto, Japan) at 212 nm. 
Fresh sample w replaced to maintain sink conditions. The 
experiment was continued for 24h [16]. 
Preparation of rat caecal medium  
Albino rats weighing (150±50) g were kept on standard normal diet 
and water and acclimatized for 10 d. Rats were placed in the cage 
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with cage environments having temperatures around 25 °C to 
maintain minimum humidity. Rats were separated into groups and 
placed separately to avoid interaction between them. The condition 
of the rats was monitored every day and the weight of rats was 
weighed for a week.1 ml of 1% w/v solution of locust bean gum in 
distilled water was administered orally in order to induce the 
enzymes, which are specified for the biodegradation of the locust 
bean gum during its passage through the colon. This treatment was 
continued for 2, 4 and 6 d in different sets of animals for enzyme 
induction. Rats were anaesthetized with diethyl ether, dissected and 
caecal contents were removed in presence of CO2. The caecal 
contents were then transferred into the simulated colonic fluid (SCF, 
pH 7.0), to produce 2% caecal dilution. The formulation, which was 
previously subjected to in vitro drug release studies in SGF (pH 1.2) 
and SIF (pH 7.5) were immersed in the simulated colonic fluid (SCF, 
pH 7.0). To maintain anaerobic environment CO2
The release of the final optimized formulation was carried out with 
the addition of rat caecal contents (2% w/v) to observe the effect of 
the caecal enzymes on the release rate of the drug. Samples obtained 
at regular intervals were filtered through a 0.22 µm membrane filter 
(Millipore, India) and analyzed using UV-Visible Spectrophotometer 
(Shimadzu, Kyoto, Japan) at 212 nm. The experiment was continued 
for 24h. 
 gas was bubbled 
into the medium. The experiments were approved by the Ethical 
Committee of Anurag Pharmacy College, Faculty of Pharmaceutics, 
Kodad, Affiliated to JNTUH University, Hyderabad with ethical 
approval Reg. No. 1712/PO/a/13/CPCSEA [17]. 
In vitro release in presence of rat caecal contents 
Stability studies  
According to ICH Guidelines, an accelerated stability study has to be 
carried out on the dosage form at 40±2 °C/75±5% RH. The 
optimized formulation was placed in the stability chamber at 40±2 
°C/75±5% RH for over a period of 30 d. Entrapment efficiency and in 
vitro drug release studies were carried out and compared with the 
results of it before conducting the stability [18]. 
Release kinetic study  
All the release data were fitted to various kinetic models like zero 
order, first order Korsmeyer-Peppas, Higuchi to find out the 
mechanism of drug release from the polymeric matrix of 
microspheres [18]. 
RESULTS AND DISCUSSION 
Evaluation of optimized formulation of formulation variables 
To study the effect of variables on the characterization of 
microspheres, different batches were prepared by applying 32 full 
factorial designs. Amount of polymer (X1) and cross-linking 
agent(X2) w varied three levels, low level (-1), medium (0), and high 
level (+1). The amount of drug and sodium alginate was kept 
constant. Particle size (Y1), % entrapment efficiency (Y2), % in vitro 
drug release (Y3
 
) were selected dependant variables fig. 1. 
 
Fig. 1: Surface response graphs for particle size, % entrapment efficiency, % in vitro drug release 
 
Particle size, percentage yield, entrapment efficiency 
All the formulated batches were evaluated for particle size, 
Percentage yield, and entrapment efficiency. Results are given in 
table 3. Based on the particle distribution results, the microspheres 
produced did not have a uniform particle size distribution.  
This could be caused by the pressure difference in the shedding 
process of drug and polymer mixtures into the calcium chloride 
solutions. The average beads diameter showed that the bigger size 
was obtained while using a higher concentration of natural 
polysaccharide used. This proved that the big beads size could be 
affected by natural polysaccharide concentration [19].  
The size of the sphere decreased with increase in cross-linking agent 
concentration because of hardening of the polymer matrix and 
shrinking of size. The particle size increased with a coating of the 
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with the increase in cross-linking agent concentration forming rigid 
microspheres hence prevent the drug loss from the formed spheres. 
The entrapment efficiency increased with the increase of polymer 
concentration and amount of cross-linking agent. The reason may 
be, increase in polysaccharide concentration leads to increase in the 
viscosity of aqueous phase and highly viscous phase shows high 
drug retention capacity by preventing the migration of drug from 
droplets to surrounding media which result in more encapsulation 
efficiency [20]. 
 
Table 3: Characterization of locust bean microspheres 
Batch code LBG (X1 GA (X) (%) 2 PS (mm) )(ml) EE (%) IDR (%) 
ILBG1 0.25 4.5 0.852±0.75 38.58±2.57 99.32±0.93 
ILBG2 0.625 3 1.26±0.65 57.42±1.98 98.54±1.02 
ILBG3 1 4.5 0.853±0.77 45.89±1.08 97.83±3.74 
ILBG4 0.25 1.5 0.921±0.33 32.64±0.57 98.36±2.36 
ILBG5 0.25 3 0.876±0.57 35.15±0.65 98.29±3.85 
ILBG6 0.625 1.5 1.45±0.65 50.44±1.28 98.44±2.48 
ILBG7 1 3 0.934±0.76 47.25±2.58 96.78±2.76 
ILBG8 1 1.5 0.967±0.66 41.09±2.56 98.68±1.86 
ILBG9 0.625 4.5 1.04±0.74 48.49±1.69 95.49±3.22 
*LBG-Locust bean gum, GA-Glutaraldehyde, PS-Particle size, %EE-Entrapment efficiency, % IDR-in vitro drug release, *All readings are expressed as 
mean±standard deviation (n=3) 
 
Surface morphology 
Surface morphology of microspheres was taken at 60 x, 70 x 
magnifications. Scanning electron microscopy confirmed the 
spherical shape of the microsphere.  
The shape of all formed microspheres was found to be spherical and 
the surface morphology of the un-coated formulation of microsphere 
was rough and the coated form of the same formulation was smooth 
in the surface. This might be because of the smoothing of the surface 








Fig. 2: Scanning electron microscopy of a) group of drug loaded 
LBG-microspheres, b) surface morphology of un-coated drug-
loaded microspheres, c) coated drug loaded microsphere 
 
FTIR studies 
To investigate the interaction between drug and polymer FTIR 
studies were carried out. The FTIR Spectra for the Pure drug, 
Polymer, Microsphere formulation were analyzed. The FTIR 
Spectrum of the pure drug shows a characteristic peak at 1266.2 
cm-1 for C-N stretching vibration, 1794.7 cm-1 and 1487.9 cm-1 
indicating the presence of benzene ring and at 1602.3 cm-1 
indicates for N-H in-plane bending. Other peaks observed are 
1651.0 cm-1 for C=O stretching vibration of carboxylic acid and 
2982.8 cm-1 for acryl C-H stretching. The spectrum was 
overlapped and with the drug-loaded microsphere formulation 
and was observed that no new bond was formed and there was no 
interaction with polymer indicating good compatibility between 
the drug and the polymer (fig. 3). 
DSC studies 
The DSC studies carried out to observe the thermal behavior of drug-
loaded microspheres whether the drug was encapsulated in them or 
not. The characteristic endothermic peak appeared at 298.38 °C and 
163.50 °C for Mesalamine and Locust bean gum respectively was 
disappeared in drug-loaded microsphere formulation but had a 
characteristic new peak at 207.78 °C (fig. 4). A significant peak 
change in DSC thermogram confirmed that mesalamine had 
experienced chemical interaction and had been entrapped into the 
microsphres. This explains the molecular encapsulation of 
mesalamine in the matrix of the polymer. 
Sirisha et al. 
Int J App Pharm, Vol 10, Issue 1, 2018, 86-93 
 
 
Fig. 3: FTIR results of pure drug, locust bean gum, MSL-loaded locust bean gum microspheres, *MSL-mesalamine, LBG-locust bean gum, 
LBGF-locust bean gum formulation 
 
 
Fig. 4: DSC curves of the pure drug, locust bean gum, MSL-loaded locust bean gum microspheres, *MSL-mesalamine, LBG-locust bean gum, 
LBGF-locust bean gum formulation 
 
In vitro drug release 
All formulation batches were subjected to in vitro drug release 
studies in SGF (pH-1.2) for first 2h and SIF (pH-7.4) for 3h later and 
in SIF (pH-6.8) up to 24h to observe the drug release of the 
microspheres in the stomach, small intestine, large intestine 
respectively. The amount of drug release for the optimized 
formulation in first 5h studies showed that the polymer matrix 
remained intact in the stomach and small intestine environment and 
the gelling property of the polymer retards the drug release from the 
matrix. There was an initial release of drug in the first 2h of the 
studies indicating the un-entrapped drug on the surface of the 
matrix of the microsphere but later due to the formation of the 
viscous gel layer around the sphere, the drug release was retarded. 
The polymer matrix could retard the drug release up to around 7h. 
To retard the drug release up to 24 h the optimized formulation was 
coated with Eudragit S-100 in three different concentrations (4 % 
w/v, 8% w/v, 15% w/v) and the drug release studies were 
performed. Of all the formulated batches ILBG6 was selected as the 
optimized formulation which showed good entrapment efficiency. 
Due to the coating of the microsphere, the drug release was retarded 
for more than 24 h. Of the three concentrations of coating solutions 
formulation coated with 8% w/v showed good retardation and 
optimized release of drug for 24h, while the 4%w/v and 15%w/v 
formulation had a fast release before 24 h and retardation which had 
very low release even after 24 h respectively. The In vitro drug 
release studies were performed with and without rat caecal contents 
for the final optimized formulation and the release was compared. 
The amount of drug release from the formulation was found to be 
higher in the presence of rat caecal contents (98.28±4.42) % due to 
the degradation of the polymer matrix by colonic enzymes released 
by colonic bacteria than without rat caecal contents (73.58±3.49) in 
the SIF medium (fig. 5). Since being non-ionic in nature locust bean 
gum was not affected by pH or ionic strength which makes it 
efficient in retard the drug release in the gastric and intestinal pH 
and once reaches the large intestine the polymer gets degraded by 
the microfloral enzymes of colonic bacteria which cause the 
breakdown of the 1, 4-linked β-D-mannopyranose units of natural 
polymer and thus cause the release of the drug locally in colon. To 
extend the retardation of drug release the optimized formula was 
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degrade below the pH 7. The presence of rat caecal contents increase 
the drug release because of the bacterial enzymes present in them. 
The polymer concentration and cross-linking agent amount had a 
significant effect on the size, shape, surface morphology and 
entrapment efficiency and in vitro drug release profiles of the 
formed microspheres. The molecular structure of the polymer and 
the polymer coating of drug release and the rat caecal contents have 
a significant effect on the drug release from the microspheres. 
Stability studies 
The entrapment efficiency and in vitro drug release had no 
significant decrease when compared with the formulation before 
stability studies. Hence the formulations are found to be stable. 
Release kinetic study  
All the release data were fitted to various kinetic models like zero 
order, first order Korsmeyer-Peppas, Higuchi to find out the 
mechanism of drug release from the polymeric matrix of 
microspheres. The in vitro release from the core microsphere 
(Locust bean gum microsphere) was found to be following Higuchi 
diffusion since the plots provide the highest linearity.  
For all LBG-microspheres, then value as per Korsmeyer-Peppas 
model was found to be between 0.44 and 0.82, indicating anomalous 
release behavior of the drug, i.e., both diffusion and dissolution of the 
hydrated polymer matrix might be responsible for drug release from 
the microsphere. Coated microspheres followed Fickian kinetics 
with the value n<0.44 as per the Korsmeyer-Peppas model which 
might be due to relaxation of the polymer matrix; followed by the 
diffusion matrix (table 4).  
The release of drug from the coated microspheres is by the first 
relaxation of the matrix by dissolution of polymer matrix 









Sirisha et al. 




Fig. 5: In vitro drug release curves of a) ILBG1-ILBG5,b) ILBG6-ILBG9,c) Eudragit-coated drug-loaded microspheres of ILBG6,d) Eudragit-
coated(8%w/v) drug-loaded microspheres in presence and absence of rat caecal contents of ILBG6, *All readings are expressed as 
mean±standard deviation (n=3), *
 
CDR-Cumulative percentage drug release 
Table 4: Comparison of different dissolution kinetic models 
Formulation Zero-order First order Higuchi Korsmeyer-Peppas 
R R2 R2 R2 N 2 
ILBG1 0.894 0.976 0.980 0.959 0.52 
ILBG2 0.898 0.987 0.993 0.986 0.61 
ILBG3 0.942 0.896 0.992 0.984 0.76 
ILBG4 0.946 0.966 0.996 0.980 0.67 
ILBG5 0.971 0.974 0.989 0.983 0.44 
ILBG6 0.939 0.987 0.990 0.985 0.78 
ILBG7 0.954 0.967 0.979 0.961 0.82 
ILBG8 0.969 0.950 0.976 0.968 0.46 
ILBG9 0.964 0.965 0.976 0.963 0.49 
 
CONCLUSION 
The ionic gelation method was proposed for the preparation of 
locust bean gum microspheres was found to be a good technique to 
entrap mesalamine and was capable of targeting the release of the 
anti-inflammatory drug (mesalamine) in the colon for the 
management of colitis. Various parameters studied such as particle 
size, entrapment efficiency, in vitro drug release the capability of 
locust bean gum microspheres in delivering the therapeutic moiety 
to the colon. Ther locust bean gum microspheres formulations 
require for further in vivo studies to scale up the technology. 
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